Pathogen: clinical or host-associated sample from ... - BioSample

Pathogen: clinical or host-associated sample from Escherichia coli

Identifiers: BioSample: SAMN46941623; Sample name: AR-1305; SRA: SRS24213508

Organism: Escherichia coli
cellular organisms; Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Enterobacteriaceae; Escherichia

Package: Pathogen: clinical or host-associated; version 1.0

Attributes

isolate	AR-1305
collected by	missing
collection date	2021
geographic location	USA
host	Homo sapiens
host disease	missing
isolation source	Bronchial washings
latitude and longitude	missing
panel_id	MULTI-17
MLST	ST477_Pasteur, ST405_Achtman

BioProject: PRJNA953359
Retrieve all samples from this project

Submission: CDC, Thao Masters; 2025-02-21

Antibiogram
Antibiotic	Resistance phenotype	Measurement sign	Measurement	Measurement units	Laboratory typing method	Laboratory typing method version or reagent	Testing standard
amikacin	susceptible	<=	1	mg/L	MIC	96-Well Plate	CLSI
ampicillin	susceptible	>	32	mg/L	MIC	96-Well Plate	CLSI
ampicillin-sulbactam	resistant	>	32/16	mg/L	MIC	96-Well Plate	CLSI
aztreonam	resistant	>	32	mg/L	MIC	96-Well Plate	CLSI
cefepime	not defined	>	32	mg/L	MIC	96-Well Plate	CLSI
cefiderocol	susceptible	==	4	mg/L	MIC	96-Well Plate	CLSI
cefotaxime	resistant	>	64	mg/L	MIC	96-Well Plate	CLSI
cefotaxime-clavulanic acid	not defined	>	32/4	mg/L	MIC	96-Well Plate	missing
cefoxitin	resistant	>	16	mg/L	MIC	96-Well Plate	CLSI
ceftazidime	resistant	>	128	mg/L	MIC	96-Well Plate	CLSI
ceftazidime-avibactam	resistant	>	16/4	mg/L	MIC	96-Well Plate	CLSI
ceftazidime-clavulanic acid	not defined	>	64/4	mg/L	MIC	96-Well Plate	CLSI
ceftolozane-tazobactam	resistant	>	16/4	mg/L	MIC	96-Well Plate	CLSI
ceftriaxone	resistant	>	32	mg/L	MIC	96-Well Plate	CLSI
ciprofloxacin	resistant	>	8	mg/L	MIC	96-Well Plate	CLSI
colistin	intermediate	==	0.5	mg/L	MIC	96-Well Plate	CLSI
ertapenem	resistant	>	8	mg/L	MIC	96-Well Plate	CLSI
gentamicin	resistant	>	16	mg/L	MIC	96-Well Plate	CLSI
imipenem	resistant	>	16	mg/L	MIC	96-Well Plate	CLSI
Imipenem-EDTA-PA	not defined	==	0.5	mg/L	MIC	96-Well Plate	missing
imipenem-relebactam	resistant	==	8/4	mg/L	MIC	96-Well Plate	CLSI
levofloxacin	resistant	>	8	mg/L	MIC	96-Well Plate	CLSI
meropenem	resistant	>	8	mg/L	MIC	96-Well Plate	CLSI
meropenem-vaborbactam	resistant	>	16/8	mg/L	MIC	96-Well Plate	CLSI
minocycline	resistant	==	16	mg/L	MIC	96-Well Plate	CLSI
omadacycline	susceptible	==	1	mg/L	MIC	96-Well Plate	missing
piperacillin-tazobactam	resistant	>	128/4	mg/L	MIC	96-Well Plate	CLSI
plazomicin	susceptible	==	1	mg/L	MIC	96-Well Plate	missing
tetracycline	resistant	>	32	mg/L	MIC	96-Well Plate	CLSI
tigecycline	susceptible	<=	0.5	mg/L	MIC	96-Well Plate	missing
tobramycin	intermediate	==	4	mg/L	MIC	96-Well Plate	CLSI
trimethoprim-sulfamethoxazole	resistant	>	8/152	mg/L	MIC	96-Well Plate	CLSI

Accession:: SAMN46941623
ID:: 46941623

SRA

BioSample

National Center for Biotechnology Information

Result Filters

Send to:

Pathogen: clinical or host-associated sample from Escherichia coli

Supplemental Content

Related information

Recent activity